Tredegar quarterly earnings rise year over year as six-month net income softens and operating cash flow reverses sign

Bottom line

Tredegar Corporation closed both the three-month reporting period and the six-month year-to-date period in profitability, with diluted earnings per share attributable to the parent of $0.17 per diluted share USD/SHARES for the three months ended June 30, 2026 and $0.34 per diluted share USD/SHARES for the six months ended June 30, 2026. The prior-year comparatives sit at $0.05 per diluted share USD/SHARES for the three months ended June 30, 2025 and $0.34 per diluted share USD/SHARES for the six months ended June 30, 2025. Net Income (Loss) Attributable to Parent registered at $6,017,000 USD for the three months ended June 30, 2026 and $11,678,000 USD for the six months ended June 30, 2026, against prior-year comparatives of $1,731,000 USD for the three months ended June 30, 2025 and $11,832,000 USD for the six months ended June 30, 2025. The filing covered by this analysis is the 10-Q for period-ended-2026-06-30, filed under accession 0001628280-26-054593 by CIK 0000850429 for the company identified as TREDEGAR CORP under ticker TG.

Management presents the quarter and year-to-date results as part of an ongoing two-segment structure, Aluminum Extrusions and High Performance Films, after renaming the former PE Films segment in the prior fiscal year. The filing narrative also notes the completed divestiture of the flexible packaging films business headquartered in Brazil and the recasting of that business as discontinued operations beginning in the fourth quarter of the prior fiscal year, alongside an announcement that the Company has initiated a process to terminate and settle its U.S. defined benefit pension plan. The accounting narrative further flags an October ASU related to disclosure-area updates, a November ASU on expense disclosures, and a clarifications update on interim reporting, none of which management expects to have a material impact on the consolidated financial statements upon adoption.

On the dimensions the catalog actually authorizes, the year-over-year signal is mixed. Earnings Per Share, Diluted for the six months ended June 30, 2026 is authorized as flat versus the six months ended June 30, 2025 (profit to profit), while Earnings Per Share, Diluted for the three months ended June 30, 2026 is authorized as an increase versus the three months ended June 30, 2025 (profit to profit). Net Income (Loss) Attributable to Parent for the six months ended June 30, 2026 is authorized as a decrease versus the six months ended June 30, 2025 (profit to profit), and Net Income (Loss) Attributable to Parent for the three months ended June 30, 2026 is authorized as an increase versus the three months ended June 30, 2025 (profit to profit).

The filing authorizes a softer half-year net-income direction even as the quarterly net-income direction improves, and the quarter-to-date EPS direction is an increase while the year-to-date EPS direction is flat. The condensed consolidated financial statements were prepared on a basis consistent with the audited financials in the Annual Report on Form referenced in the source narrative, and management flags that interim results are not necessarily indicative of full-year outcomes. Readers can place this report alongside prior coverage such as BioLife Solutions Reports Loss-to-Profit Swing on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period as context for how a single filing can carry divergent period-over-period signals across the three-month and six-month windows.

The filing evidence contains no peer or industry comparison.. The filing evidence contains no peer or industry comparison. The filing evidence does not attribute this change to any single cause..

Financial performance

05 per diluted share USD/SHARES for the three months ended June 30, 2025; the authorized year-over-year reading is an increase, with profit recorded in both the current quarter and the prior-year quarter. 34 per diluted share USD/SHARES for the six months ended June 30, 2025; the authorized year-to-date reading is flat, with profit in both windows. - Net Income (Loss) Attributable to Parent was $6,017,000 USD for the three months ended June 30, 2026 and was $1,731,000 USD for the three months ended June 30, 2025, which the authorized comparison characterizes as higher year over year, with profit in both quarters.

- Net Income (Loss) Attributable to Parent was $11,678,000 USD for the six months ended June 30, 2026 and was $11,832,000 USD for the six months ended June 30, 2025, which the authorized year-to-date comparison characterizes as lower than the prior-year window, with profit in both. - Management explicitly cautions that the results for the three and six months ended June are not necessarily indicative of the full year, framing both windows as interim snapshots rather than run-rate signals. - Accounting context includes the rename of the segment formerly known as "PE Films" to "High Performance Films" and the prior renaming of polyethylene overwrap films to advanced packaging films, with no operational change to the segment; the Company continues to report two segments, Aluminum Extrusions and High Performance Films.

- The completed sale of Terphane (the flexible packaging films business in Brazil) to Oben Group is presented as discontinued operations from the fourth quarter of that year onward, so the year-to-date and quarterly results reflect a continuing-operations perimeter that differs from earlier periods. - The Company states that the November pension plan termination and settlement was completed, with the remaining obligation transferred to Massachusetts Mutual Life Insurance Company; pension expense recognized for the plan was described as immaterial in both interim windows, so the EPS and net income lines above are not visibly reshaped by ongoing pension service cost.

- Management discusses three accounting standards not yet adopted (an ASU updating various ASC paragraphs, an expense-disclosure ASU effective for annual and interim periods beginning after a future December cutoff, and an interim-disclosure clarification ASU effective for fiscal years beginning after a future December cutoff) and concludes that none is expected to have a material impact on the consolidated financial statements, leaving the current reporting basis unchanged. - The filing evidence does not attribute this change to any single cause.

- The filing evidence contains no peer or industry comparison. - No segment revenue, segment operating profit, segment-level asset base, segment-level capex split, segment-level headcount, gross margin, operating margin, effective tax rate, share count, weighted-average diluted share count, share-based compensation, interest expense, debt balance, dividend declaration, share repurchase activity, working capital line, restructuring charge, impairment, or one-time gain/loss figures are exposed in this section's filing evidence, so any further reconciliation of EPS or net income to underlying drivers cannot be written here.

Readers looking to translate these headline outcomes into return on invested capital can pair the reporting with an ROI Calculator as an external reference.

Operating drivers and segments

- The reporting entity continues to operate two reportable segments: Aluminum Extrusions and High Performance Films, with the previously separate Flexible Packaging Films business having been presented as discontinued operations since the fourth quarter of the prior calendar year following the completed sale to Oben Group. - Aluminum Extrusions operates on a non-calendar fiscal year, which causes the segment's fiscal second quarter to reference periods ended in the referenced month for both the current and prior-year comparative reporting, a treatment the issuer states is not material to consolidated results.

- High Performance Films is the renamed former "PE Films" segment, with no operational changes accompanying the rebranding; the previously named polyethylene overwrap films product is now labeled advanced packaging films. - Segment-level revenue, profit, and margin detail for the quarter and half-year are not disclosed within the narrative captured for this section, so the magnitude and direction of any segment-level mix shift, volume versus price split, or margin movement is not analyzable here. - Management frames the Flexible Packaging Films divestiture as a discrete event with a November completion date, and characterizes all Terphane historical results as discontinued operations beginning with the fourth quarter of the prior year, with no ongoing consolidated contribution from that business.

- Management characterizes the off-calendar fiscal year of the Aluminum Extrusions segment as immaterial to consolidated financial results, while acknowledging intra-period cash funding or receipt mechanics tied to the gap between the segment's and the parent's quarter-ends. - Management describes accounting standards not yet adopted in the cited references and states that no material impact is expected on the consolidated financial statements and related disclosures, with ongoing evaluation limited to one specific expense-disclosure update.

- Management describes the defined benefit pension plan as having ceased accruing service credits as of a referenced date and as entering a termination and settlement process initiated through a subsequent announcement, executed via lump sum distributions and annuity contract purchases.

Cash flow and capital

- Operating cash flow for the six-month year-to-date period was positive, having swung from a use of cash in the prior-year comparative for the same six-month window, which the filing evidence records as an authorized increase (a transition from a use to a source). - Investing cash flow for the six-month year-to-date period was a use of cash, having moved in the opposite direction from the prior-year comparative, which the evidence records as a decrease (the prior-year comparative was a source rather than a use). - Financing cash flow for the six-month year-to-date period was a source of cash, having moved higher from the prior-year comparative for the same six-month window, which the evidence records as an authorized increase (the prior-year comparative was a use of cash). - Capital expenditures for the six-month year-to-date period were higher than the prior-year comparative for the same six-month window, which the evidence records as an authorized increase; both periods showed payments to acquire property, plant, and equipment, so this is a larger outflow rather than a swing from positive to negative. - Cash and cash equivalents were reported on the condensed consolidated balance sheet as of the balance sheet date. - Accounts receivable, net of the allowance for credit loss, were reported as a current asset as of the balance sheet date, and the gross balance before that allowance is also disclosed in the cited note. - Accounts payable were reported as a current liability as of the balance sheet date. - Long-term debt, excluding current maturities, was reported on the balance sheet as of the balance sheet date. - The cited note describes the Company's defined benefit pension plan: it no longer accrued benefits after the cited freeze date, the Company announced a process to terminate and settle the plan, and the termination and settlement process was completed with the remaining obligation transferred to Massachusetts Mutual Life Insurance Company; pension expense for the plan was immaterial for both the three and six months ended June in the cited years, and no segment-level cash-flow attribution is disclosed. - The cited note also describes the Other Post-Retirement Benefits obligation, which had been realized into the income statement during the fourth quarter of the cited year. - The filing evidence does not attribute this change to any single cause. - The filing evidence does not disclose segment-level detail for this dimension. - The filing does not disclose a peer or industry comparison for cash flow or balance-sheet metrics. The filing evidence contains no peer or industry comparison.

Analyst inference is bounded by what the catalog authorizes: operating cash flow turned positive while capital spending rose, suggesting working-capital or earnings improvement funded higher investment, and the swing in investing cash flow plus the swing in financing cash flow together offset each other against the operating inflow to produce the period's net change in cash. The pension termination and settlement, which transferred the remaining obligation to Massachusetts Mutual Life Insurance Company, is a non-cash balance-sheet repositioning disclosed in the cited note rather than a recurring operating item, and no segment-level cash-flow detail is available in the filing evidence. No buy/sell instruction, target, or forecast is offered.

Peer and historical context

- For the six-month year-to-date window, net income attributable to the parent moved from a profit in the prior-year period to a lower profit in the current period under 10-Q filed by TREDEGAR CORP for period-ended-2026-06-30 and accessible at 0001628280-26-054593. - For the three-month period, net income attributable to the parent moved from a profit in the prior-year quarter to a higher profit in the current quarter, while basic and diluted earnings per share rose in parallel, consistent with the authorized year-over-year direction. - Operating cash flow for the six-month year-to-date window swung from a use of cash in the prior-year period to a source of cash in the current period, a directionally favorable turn versus history even as headline earnings softened on a six-month basis.

- The headline earnings picture is not uniformly stronger: the six-month net income line is lower than the prior year despite the operating-cash-flow improvement, so any read framed as a clean year-over-year rebound is incomplete on the evidence before us. - Reported facts from the cited note, including the derivative hedge tables and the segment count, are presented only for the issuer itself, which limits how far a quarter-versus-prior-quarter contrast can be stretched into a structural read.

Reading the authorized period comparisons together, the period presented in period-ended-2026-06-30 shows a quarter that improved year over year on the bottom line, set against a six-month year-to-date picture in which net income receded from a prior-year profit and operating cash flow reversed sign. Because the authorized list constrains how each line may be described, the year-to-date operating-cash-flow improvement and the quarter's higher net income are the cleanest signals of how the current period differs from the six months ended June 30, 2025 and the three months ended June 30, 2025, and readers tracking earnings momentum can pair this with related quarter-and-six-month reads such as the BioLife Solutions loss-to-profit swing piece to frame the direction of each line.

No external peer set, industry benchmark, or historical multi-year run is included in the filing's quoted evidence. The excerpt references only Tredegar's two reportable segments (Aluminum Extrusions and High Performance Films) and its own derivatives and pension disclosures, with no third-party comparator values against which to set the issuer's quarter or year-to-date results. The filing evidence contains no peer or industry comparison.

Similarly, the filing does not break the cited quarter and six-month net-income moves into segment-level contribution, and the quoted source narrative covers only the issuer's own derivatives, pension freezes, and other post-retirement benefit figures, with no restated prior-period history beyond the authorized comparisons. The filing evidence does not disclose segment-level detail for this dimension.

The reason the six-month net-income line is lower than the prior year, even as operating cash flow turned positive, is not something the filing evidence attributes to any single line item or event. The filing evidence does not attribute this change to any single cause. Readers evaluating the period in period-ended-2026-06-30 should treat the quarter-versus-prior-quarter gain and the year-to-date earnings decline as separate authorized signals, with the operating-cash-flow reversal as a third, distinct authorized signal, rather than as a single coherent trend.

Scenario analysis

- Tredegar's reported three-month net income attributable to the parent was a profit of $6,017,000 USD for the three months ended June 30, 2026, higher than the prior-year three-month profit of $1,731,000 USD for the three months ended June 30, 2025, a profit-to-profit move the machine authorizes as an increase. - The six-month year-to-date picture is the opposite shape: net income attributable to the parent of $11,678,000 USD for the six months ended June 30, 2026 sat below the prior-year six-month profit of $11,832,000 USD for the six months ended June 30, 2025, a profit-to-profit move the machine authorizes as a decrease. - That combination — a quarter that improved against the prior year but a half-year window that deteriorated — is the binding pivot that the three scenarios below branch from, and readers should treat it as the anchor rather than as a contradiction. - Earnings per share, diluted, stayed in profit territory across both windows. The reported direction is flat for the six-month comparison and increase for the quarterly comparison, both on a profit-to-profit transition. - Management's segment framing — Bonnell Aluminum in Aluminum Extrusions and the surface protection and packaging lines in High Performance Films — sets the perimeter a base case must respect, and the cited note on segment detail is the only structural handle on what the filing does and does not disclose at the segment level. - The filing evidence does not attribute this change to any single cause.

- An upside read leans on the quarterly improvement, with diluted EPS moving up against the prior-year quarter while staying in profit territory — a profit-to-profit transition the machine authorizes as increase. - Operating cash flow across the six-month window is authorized as a shift from negative to positive, and financing cash flow is authorized as a shift from negative to positive across the same six months, both consistent with renewed cash generation rather than reliance on asset sales. - Investing cash flow is authorized as a shift from positive to negative across the six months, and payments to acquire property, plant, and equipment are authorized as higher than the prior-year six-month period, which the upside frame can read as reinvestment rather than retreat. - Under that lens, the half-year decline in net income reflects front-loaded absorption rather than structural erosion, and the quarter is the early signal that returns follow as the reinvested capacity comes online.

- The downside read starts from the same binding anchor but weights it differently: net income attributable to the parent is lower than the prior-year six-month period on a profit-to-profit basis, and the half-year diluted EPS line is authorized as flat against a higher prior-year base, which limits the credit a reader can give the quarter alone. - Investing cash flow moving from positive to negative across the six months is authorized as a decrease, and the higher level of capital expenditure represents a real cash outlay rather than a clean signal of demand strength. - The downside frame must also respect that the cited note on segment detail is the only structural disclosure in the filing, so any segment-level cause story is closed off at the source and readers should not infer one. - The filing evidence does not attribute this change to any single cause.

Risks and what to watch

- Reported facts: Tredegar's three-month and six-month year-to-date results both showed a profit attributable to parent in the current period alongside a profit in the prior-year comparative. The current quarter net income attributable to parent was $6,017,000 USD for the three months ended June 30, 2026, against the prior-year comparative of $1,731,000 USD for the three months ended June 30, 2025. The six-month year-to-date net income attributable to parent was $11,678,000 USD for the six months ended June 30, 2026, against the prior-year comparative of $11,832,000 USD for the six months ended June 30, 2025.

- Management explanations: The filing's narrative highlights that fixed-price firm sales commitments and related hedging instruments generally carry short durations, and that aluminum futures contracts are designated as cash flow hedges with the effective portion reclassified from accumulated other comprehensive income (loss) to cost of goods sold. Management also notes that the Aluminum Extrusions and High Performance Films segments are the reportable structure, with EBITDA from ongoing operations as the key profitability measure used by the CODM (Tredegar's President and Chief Executive Officer).

Tax-rate commentary references research and development tax credits in the first six months of the earlier comparative year and a mix of lower pre-tax income and higher nondeductible discrete items as a percentage of pre-tax income in the first six months of the current year. - Analyst inference: The filing evidence does not attribute this change to any single cause. - Counter-evidence: The half-year profit-to-profit comparison for net income attributable to parent shows a decrease versus the prior-year comparative, which sits against a quarter that is higher year over year.

That tension between the two windows is the most notable counter-signal in the reported numbers and is a natural place to check whether the second quarter was the swing quarter or whether the first quarter carried a heavier drag that the second quarter only partially offset. - Unknowns: The filing does not provide segment-level net income detail in the quoted context, so the contribution of Aluminum Extrusions versus High Performance Films to the reported profit figures cannot be separated from what is in evidence here.

The filing evidence also offers no peer or industry benchmark against which to size the year-over-year move. The filing evidence contains no peer or industry comparison. The filing evidence does not disclose segment-level detail for this dimension.

- Metrics to watch next period: The expected reclassification of unrealized after-tax gains on aluminum derivative instruments from accumulated other comprehensive income (loss) to earnings over the coming months, the realized impact of discontinued hedges (which the filing says was not material in the periods reported), segment EBITDA from ongoing operations under the Aluminum Extrusions and High Performance Films structure, and the effective tax rate reconciliation against the statutory rate are the items most directly tied to the disclosed exposures.

Item 3 Note 4